In December, Novo Nordisk announced that it will advance FIAsp, an ultra-rapid-acting version of Novolog (insulin aspart), directly into phase 3 trials in late 2013 (the...

Important takeaways from Barcelona.

Over the course of their lifetimes, roughly half of all people with diabetes develop diabetic neuropathy, which affects the nerves and can cause feelings of numbness and...

Our trip to Berlin brought new insights on implantable GLP-1, the latest in CGM and the artificial pancreas, and debates on early insulin therapy.

For Valentine’s Day, we are asking you to consider extending your love to children who have diabetes but who don’t have access to treatment and medicine. This week,...

Kelly reflects on a major advance in obesity treatment and highlights a memorable day for diabetes at the Major League Baseball Hall of Fame.

On September 13, the New York City Board of Health approved Mayor Michael Bloomberg’s proposed regulation nearly unanimously. The regulation bans the sale of any soda or...

(S)he said what!?

On March 1, Vivus started its Save Now! program, which sets a discounted price of $75 for one 30-day supply of the company’s weight management medication Qsymia (7.5 mg...

(S)he said what!?

To mark the end of this month’s 72nd American Diabetes Association (ADA) Scientific Sessions in Philadelphia (see conference pearls in this issue), diaTribe editor in...

(S)he said what?!?

On November 28, CeQur announced that it had received CE Mark approval for its PaQ Insulin Delivery Device , allowing the product to be sold in Europe. The Swiss-based...

Main themes from AACE.

Wireless, cell phone-enabled, and data-to-the-cloud glucose meters are a new trend in diabetes, evidenced by the recent launch of Sanofi’s iBGStar (see test drive in...

Ever wondered if we have it better or worse than other countries? Dr. Dorothee Deiss reveals the state of diabetes care in Germany.

On February 8, Novo Nordisk received an FDA complete response letter (CRL) for Tresiba (insulin degludec) and Ryzodeg (insulin degludec/aspart). Tresiba is Novo Nordisk’...

(S)he said what?!?

In time for the beginning of this school year, DC Public Schools (DCPS) took a major step toward providing access to essential care for all its students with diabetes...

Dr. Sanjay Kaul speaks to diaTribe about the new SGLT-2 drug class.